tiprankstipranks
Trending News
More News >
Daito Pharmaceutical Co., Ltd. (JP:4577)
:4577
Japanese Market
Advertisement

Daito Pharmaceutical Co., Ltd. (4577) Income Statement

Compare
0 Followers

Daito Pharmaceutical Co., Ltd. Income Statement

Last quarter (Q3 2024), Daito Pharmaceutical Co., Ltd.'s total revenue was ¥12.03B, an increase of 13.96% from the same quarter last year. In Q3, Daito Pharmaceutical Co., Ltd.'s net income was ¥309.00M. See Daito Pharmaceutical Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
¥ 50.64B¥ 46.90B¥ 45.10B¥ 43.46B¥ 48.71B
Gross Profit
¥ 8.64B¥ 9.84B¥ 10.33B¥ 11.46B¥ 10.79B
Operating Expenses
¥ 6.02B¥ 5.95B¥ 5.12B¥ 4.91B¥ 4.88B
Depreciation and Amortization
¥ 4.33B¥ 3.66B¥ 3.87B¥ 3.31B¥ 3.15B
EBITDA
¥ 7.41B¥ 7.92B¥ 8.96B¥ 9.88B¥ 9.04B
Operating Income
¥ 2.62B¥ 3.89B¥ 5.21B¥ 6.55B¥ 5.91B
Other Income/Expenses
¥ 337.00M¥ 324.00M¥ -130.00M¥ 167.00M¥ -35.00M
Pretax Income
¥ 2.96B¥ 4.22B¥ 5.08B¥ 6.72B¥ 5.87B
Net Income
¥ 1.91B¥ 3.29B¥ 3.60B¥ 4.67B¥ 4.25B
Per Share Metrics
Basic EPS
¥ 62.72¥ 105.00¥ 113.82¥ 152.45¥ 141.36
Diluted EPS
¥ 62.72¥ 105.00¥ 113.71¥ 152.45¥ 141.36
Weighted Average Shares Outstanding
30.42M 15.69M 15.81M 15.31M 15.02M
Weighted Average Shares Outstanding (Diluted)
30.42M 15.69M 15.83M 15.31M 15.02M
Currency in JPY

Daito Pharmaceutical Co., Ltd. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis